18,426 results on '"LAMIVUDINE"'
Search Results
2. Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI (TLATOANI)
3. Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019
4. Lamivudine and Plasma Markers of Inflammation in Retinal Detachment
5. Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide
6. DTG/3TC Vs. BIC/FTC/TAF Maintenance Therapy in People Living with HIV (PASO-DOBLE)
7. Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
8. STARLITE for Unresectable High-Grade Gliomas (STARLITE)
9. Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
10. Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 (DOLCE)
11. Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) (DRIVE-SHIFT)
12. Study Evaluating the Safety, in Terms of HBV Virological Control at 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected With the HIV-1 and HBV Viruses (BI-LIGHT)
13. Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.
14. A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy (VOGUE)
15. Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease (ART-AD)
16. Lamivudine for Solid Tumors
17. Antiviral Therapy in Infants With HBV Infection
18. A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI)
19. Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment (DOVETAIL)
20. Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients (DOLAVI)
21. Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial (PICASSO)
22. Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine (VOLVER)
23. Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa (AXIS)
24. B-free Multistage Trial (B-free)
25. A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
26. Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals (AVERTAS)
27. A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
28. Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs (TAISTR)
29. Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome (AGS-RTI)
30. Triumeq in Amyotrophic Lateral Sclerosis (LIGHTHOUSE II)
31. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review.
32. UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study (PrIMO)
33. Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus (PENCIL)
34. INSTI's For The Management of HIV-associated TB (INSIGHT)
35. Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana (BMS02)
36. A Prospective Cohort of Children With HIV Infection
37. Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test (D2ARLING)
38. Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)
39. A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
40. Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study.
41. The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou.
42. Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
43. Real‐world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV‐1 aged over 50 years who are virologically suppressed.
44. A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1.
45. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments.
46. A Systematical Review on ART Use in HTLV Infection: Clinical, Virological, and Immunological Outcomes.
47. Incident Proteinuria by HIV Serostatus Among Men With Pre-–Diabetes Mellitus: The Multicenter AIDS Cohort Study.
48. Improvement in insulin sensitivity after switching from an integrase inhibitor‐based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
49. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1.
50. Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.